Bumble (BMBL) Stock Rockets 34% After Revealing AI-Powered Dating Assistant ‘Bee...
Bumble (BMBL) stock climbed 34% after introducing 'Bee,' an AI dating assistant. Q4 revenue hit $224.2M as the company plans to el...
SentinelOne (S) Stock Slides 4% Despite Record Q4 Performance on Weak Outlook
SentinelOne (S) stock declined 4% despite beating Q4 estimates with $271.2M revenue. FY2027 guidance of $1.195B-$1.205B disappoint...
Carvana (CVNA) Stock Climbs 3% on Historic 5-for-1 Stock Split Approval
Carvana (CVNA) stock jumped 3% after board approval of its first-ever 5-for-1 stock split. Trading on split-adjusted basis starts...
Apple (AAPL) Stock Rises as Company Slashes China App Store Commissions to 25%
Apple (AAPL) stock rises 0.3% after slashing China App Store fees to 25% from 30% following regulatory discussions with Chinese au...
Microsoft (MSFT) Stock Hits Decade-Low Valuation – A Buying Opportunity?
Microsoft (MSFT) stock has dropped 28% to its lowest valuation versus the S&P 500 in a decade, despite strong Azure growth and a m...
Robinhood (HOOD) Stock Slides After February Trading Metrics Show Mixed Results
Robinhood (HOOD) stock dropped 2% after-hours as February trading data revealed equity volume declined 14% from January, though cr...
Coinbase (COIN) Stock Faces Mounting Pressure as Cramer Recommends Bitcoin Over...
Jim Cramer advises buying Bitcoin over Coinbase (COIN) stock as Q4 earnings disappoint and insiders sell $84M worth of shares. Sto...
Stock Futures Gain as Oil Retreats from $100 and Bitcoin Surges Above $72,000
US stock futures climb as oil pulls back from $100, Bitcoin surges past $72K, and Fed rate cut odds shift amid Iran conflict. Late...
Morgan Stanley: AI Revolution Set to Disrupt Jobs and Energy Infrastructure by 2...
Morgan Stanley forecasts a pivotal AI breakthrough in 2026 that will transform jobs and strain power grids, with potential 12-25%...
Immutep (IMMP) Stock Plummets 80% Following Phase III Lung Cancer Study Terminat...
Immutep (IMMP) stock plummeted 80% after the company halted its Phase III NSCLC trial for futility, triggering analyst downgrades...